z-logo
open-access-imgOpen Access
Target coverage of daily cone-beam computed tomography in breath-hold image-guided radiotherapy for gastric lymphoma
Author(s) -
Shojiro Takahashi,
Takamasa Nishide,
Masato Tsuzuki,
Hiroki Katayama,
Masahide Anada,
Toshiro Kinoshita,
Shohei Kozai,
Toru Shibata
Publication year - 2021
Publication title -
bjr|open
Language(s) - English
Resource type - Journals
ISSN - 2513-9878
DOI - 10.1259/bjro.20200062
Subject(s) - image guided radiation therapy , medicine , cone beam computed tomography , nuclear medicine , radiation therapy , computed tomography , lymphoma , cone beam ct , radiology , stomach
Objectives: We evaluated retrospectively the daily target coverage using cone-beam computed tomography (CBCT) in breath-hold image-guided radiotherapy (BH-IGRT) for gastric lymphoma. Methods: BH-IGRT was performed using a prescribed dose of 30.6 Gy in 17 fractions for the whole stomach. We assessed the target coverage of the whole stomach on daily CBCT images [daily clinical target volume (CTV)], which was delineated individually by two observers. We evaluated V 95% (percentage of volume receiving ≥95% of the prescribed dose) of daily CTV. Results: In total, 102 fractions from 6 patients were assessed. The mean V 95% of daily CTV was 97.2%, which was over 95%. In two of six patients, the V 95% of daily CTV was over 95% for either observer in all fractions. One patient had significant interobserver variation ( p = 0.013). In 95 fractions (93%), the V 95% of daily CTV was over 95% for either observer. Conclusion: Daily target coverage for CTV in BH-IGRT for gastric lymphoma seems to be favorable, even when using CBCT. Advances in knowledge: A previous study ascertained good daily target coverage in BH-IGRT for gastric lymphoma using in-room CT. Even when using CBCT in our study, daily target coverage for CTV in BH-IGRT for gastric lymphoma seems to be favorable.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here